Storia in 18 fonti

UK's AstraZeneca eyeing $400b merger, report says

The United Kingdom's second-most valuable listed company, pharmaceutical firm AstraZeneca, has been revealed to have been holding talks for some time with United States-based rival Bristol Myers Squibb, or BMS, about a merger, which could result in a global pharma giant worth nearly $400 billion.

Raccontata da

www1.folha.uol.com.br

manager-magazin.de+6 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

global.chinadaily.com.cnStai leggendo6 h fa

UK's AstraZeneca eyeing $400b merger, report says

AstraZeneca and BMS in merger talks for $400B pharma giant; AstraZeneca targets $80B revenue by 2030, investing $15B in China. Signals pharma consolidation trend; antitrust scrutiny on cancer division and UK relocation risk could block or reshape the deal.

originale

Timeline cronologica

domenica 2 agosto 2026·www1.folha.uol.com.br
AstraZeneca negocia fusão com Bristol Myers Squibb em acordo de US$ 400 bi
Acordo pode criar a quarta maior farmacêutica do mundo por capitalização de mercado
domenica 2 agosto 2026·handelsblatt.com
Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb
Es wäre eine der größten Fusionen in der Wirtschaftsgeschichte. Laut einem Medienbericht wurden entsprechende Gespräche geführt. Ob es zu einem Zusammenschluss kommt ist jedoch…

UK's AstraZeneca eyeing $400b merger, report says

Confronto fonti

UK's AstraZeneca eyeing $400b merger, report says

Timeline cronologica

AstraZeneca negocia fusão com Bristol Myers Squibb em acordo de US$ 400 bi

Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb

AstraZeneca, BMS discuss $400B pharma mega-deal

Astrazeneca explores $400bn megadeal with US rival

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report

Pharma giants AstraZeneca and Bristol-Myers in reported merger talks

AstraZeneca explora possível fusão com a Bristol Myers Squibb, diz jornal

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca said to have explored Bristol Myers merger | Fortune

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

Ft, AstraZeneca tratta con Bristol Myers Squibb maxi fusione da 400 miliardi

Ft: AstraZeneca tratta con Bristol Myers Squibb fusione da 400 mld

Pharma: Astra-Zeneca erwägt wohl Mega-Fusion mit Bristol-Myers Squibb

AstraZeneca: Pharmakonzern prüft 400-Milliarden-Dollar-Fusion mit Bristol Myers

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Astrazeneca explores $400bn megadeal with US rival

AstraZeneca in talks over £300bn mega-merger with US rival – reports

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

Financial Times: 'AstraZeneca tratta con Bristol Myers Squibb per una maxi fusione da 400 miliardi' - Notizie - Ansa.it

AstraZeneca, BMS discuss $400B pharma mega-deal

Las farmacéuticas AstraZeneca y Bristol Myers Squibb negocian una fusión de 348.000 millones de euros